From: Inhibitory effect of novel Eugenol Tosylate Congeners on pathogenicity of Candida albicans
Gene | Primer | Sequence (5′–3′) | Amplicon length (bp) | Source |
---|---|---|---|---|
ALS1 | Forward Reverse | GCT CCA TCA CCT GCT GTT TC CTG AGG TGC CTG TTG TCA AG | 193 | This study |
ALS2 | Forward Reverse | TTT AAG GCT GGC ACC AAC AC ATT GTG AAC CCC ATT GCA CC | 203 | This study |
ALS3 | Forward Reverse | CTA CCG CTG TGA CCA CCT TA CAG TTT CCC CAA TTG GTG CA | 153 | This study |
ALS9 | Forward Reverse | CGA TTT CAG TTA GCA CCG CA CGT TGA AGT TGG CAC CTC TC | 242 | This study |
CPH1 | Forward Reverse | GTC GCC ACC CCA ACC TAT AT AGG AAA CCC AGA AGC GTC AT | 240 | This study |
HWP1 | Forward Reverse | CTG AAC CTT CCC CAG TTG CT CGA CAG CAC TAG ATT CCG GA | 174 | This study |
SAP1 | Forward Reverse | TTT GGT GGG GTT GAC AAA GC ATG ACC TTG ACC GTC CAG TT | 234 | This study |
SAP2 | Forward Reverse | CCG TTG GAT TTG GTG GTG TT AGC ATT ATC AAC CCC ACC GA | 239 | This study |
SAP3 | Forward Reverse | TGG TCC CCA AGG TGA AAT CA TGT CCT TGA CCA GCT TGA CA | 201 | This study |
PLB1 | Forward Reverse | ATA TGC TCC TGG TCC GGT TT ATT GCT CTA TAC CCT CCG CC | 231 | This study |
ACT1 | Forward Reverse | TGG TGA TGA AGC CCA ATC CA CAT TGG AGC TTC GGT CAA CA | 169 | This study |
PMA1 | Forward Reverse | GAA GGT GCT ACT GAT GCT GC GCA ACA TCA GCG AAA ATG GC | 242 | This study |
RPP2B | Forward Reverse | ACA CCT CTC CAT CAG CTT CT TGG GAC AGA AGC TAA TTT GGT G | 155 | This study |